OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 189 citing articles:

Cannabidiol in Anxiety and Sleep: A Large Case Series
Scott Shannon, Nicole Lewis, Heather Lee, et al.
The Permanente Journal (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 359

A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Michelle Sexton, Carrie Cuttler, John S. Finnell, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 131-138
Open Access | Times Cited: 271

Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
Dan Jin, Kaiping Dai, Zhen Xie, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 257

Pharmaceutical and biomedical analysis of cannabinoids: A critical review
Cinzia Citti, Daniela Braghiroli, Maria Angela Vandelli, et al.
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 147, pp. 565-579
Open Access | Times Cited: 222

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211

Clinicians’ Guide to Cannabidiol and Hemp Oils
Harrison VanDolah, Brent A. Bauer, Karen F. Mauck
Mayo Clinic Proceedings (2019) Vol. 94, Iss. 9, pp. 1840-1851
Open Access | Times Cited: 198

Clinical applications of hallucinogens: A review.
Albert Garcia‐Romeu, Brennan Kersgaard, Peter H. Addy
Experimental and Clinical Psychopharmacology (2016) Vol. 24, Iss. 4, pp. 229-268
Open Access | Times Cited: 175

Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Tzu-Tang Wei, Mark Chandy, Masataka Nishiga, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1676-1693.e23
Open Access | Times Cited: 82

Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference
Qing‐Rong Liu, Ana Canseco-Alba, Hai‐Ying Zhang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 134

The Pharmacological Basis of Cannabis Therapy for Epilepsy
Doodipala Samba Reddy, Victoria M. Golub
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 357, Iss. 1, pp. 45-55
Open Access | Times Cited: 119

Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer
Brigitta Kis, Feng Chen Ifrim, Valentina Buda, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5905-5905
Open Access | Times Cited: 116

Migraine and Tension-Type Headache
Rebecca Burch
Medical Clinics of North America (2018) Vol. 103, Iss. 2, pp. 215-233
Closed Access | Times Cited: 108

Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome
Thangam Venkatesan, David J. Levinthal, B U.K. Li, et al.
Neurogastroenterology & Motility (2019) Vol. 31, Iss. S2
Open Access | Times Cited: 105

Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Samridhi Lal, Anusmita Shekher, Puneet Kumar, et al.
Pharmacological Research (2020) Vol. 163, pp. 105302-105302
Closed Access | Times Cited: 75

Detecting and understanding potential stigma among medical cannabis users in Germany
Velimir Borojevic, Felicitas Söhner
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
Danielle N. Rhyne, Sarah L. Anderson, Margaret Gedde, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2016) Vol. 36, Iss. 5, pp. 505-510
Open Access | Times Cited: 82

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Staci A. Gruber, Kelly A. Sagar, Mary Kathryn Dahlgren, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 76

Quantitative Determination of Cannabinoids in Cannabis and Cannabis Products Using Ultra‐High‐Performance Supercritical Fluid Chromatography and Diode Array/Mass Spectrometric Detection
Wang Mei, Yanhong Wang, Bharathi Avula, et al.
Journal of Forensic Sciences (2016) Vol. 62, Iss. 3, pp. 602-611
Closed Access | Times Cited: 66

The Use of Cannabis for Headache Disorders
Bryson Lochte, Alexander Beletsky, Nebiyou K. Samuel, et al.
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 61-71
Open Access | Times Cited: 65

Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction
Aaron Elkins, Myrna A. Deseo, Simone Rochfort, et al.
Journal of Chromatography B (2019) Vol. 1109, pp. 76-83
Closed Access | Times Cited: 65

Endocannabinoid System and Migraine Pain: An Update
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 59

Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis
Ashna Talwar, Emily R. Estes, Rajender R. Aparasu, et al.
Experimental Neurology (2022) Vol. 359, pp. 114238-114238
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top